Systemic high-sensitivity c-reactive protein level in pseudoexfoliation syndrome and pseudoexfoliation glaucoma

Journal of Glaucoma

Volumn 19, Issue 6, 2010, Pages 373-376

  Yüksel, Nurşen ^a   Pirhan, Dilara ^a   Altntaş, Özgül ^a   Çaǧlar, Yusuf ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

high sensitivity C reactive protein; pseudoexfoliation glaucoma; pseudoexfoliation syndrome; vascular endothelial dysfunction

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; URIC ACID;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; EXFOLIATION SYNDROME; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MALE; NEPHELOMETRY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PSEUDOEXFOLIATION; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; BLOOD; BLOOD PRESSURE; BODY CONSTITUTION; COMPARATIVE STUDY; GLAUCOMA; INTRAOCULAR PRESSURE; METABOLISM; PHOTOMETRY;

AGED; BLOOD PRESSURE; BODY CONSTITUTION; C-REACTIVE PROTEIN; EXFOLIATION SYNDROME; FEMALE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; NEPHELOMETRY AND TURBIDIMETRY; PROSPECTIVE STUDIES;

EID: 77956024145     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e3181bdb570     Document Type: Article

References (33)

1. Schlötzer-Schrehardt UM, Koca MR, Naumann GOH, et al. Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder? Arch Ophthalmol. 1992;110:1752-1756.
2. Mitchell P, Wang JJ, Smith W. Association of exfoliation syndrome with increased vascular risk. Am J Ophthalmol. 1997; 124:685-687.
3. Naumann GOH, Schlötzer-Schrehardt U, Küchle M. Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Ophthalmology. 1998;105:951-968.
4. Shrum KR, Hattenhauer MG, Hodge D. Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol. 2000;129:83-86.
5. Streeten BW, Li ZY, Wallace RN, et al. Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol. 1992;110:1757-1762.
6. Schlötzer-Schrehardt U, Naumann GOH. Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol. 2006;141:921-937.
7. Li ZY, Streeten BW, Wallace RN. Association of elastin with pseudoexfoliative material: an immunoelectron microscopic study. Curr Eye Res. 1988;7:1163-1172.
8. Roh YB, Ishibashi T, Ito N, et al. Alteration of microfibrils in the conjunctiva of patients with exfoliation syndrome. Arch Ophthalmol. 1987;105:978-982.
9. Streeten BW, Bookman L, Ritch R, et al. Pseudoexfoliative fibrillopathy in the conjunctiva: a relation to elastic fibers and elastosis. Ophthalmology. 1987;94:1439-1449.
10. Schlötzer-Schrehardt U, Küchle M, Naumann GOH. Electron microscopic identification of pseudoexfoliative material in extrabulbar tissue. Arch Ophthalmol. 1991;109:565-570.
11. Ritland JS, Egge K, Lydersen S, et al. Exfoliative glaucoma and primary open-angle glaucoma: associations with death causes and comorbidity. Acta Ophthalmol Scand. 2004;82:401-404.
12. Bleich S, Roedl J, Von Ahsen N, et al. Elevated homocysteine levels in aqueous humor of patients with pseudoexfoliation glaucoma. Am J Ophthalmol. 2004;138:162-164.
13. AltintaşO, Maral H, Yüksel N, et al. Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary openangle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2005;243: 677-683.
14. Torres JL, Ridker PM. Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events. Curr Opin Cardiol. 2003;18:471-478.
15. Kesler A, Irge D, Rogowski O, et al. High-sensitivity Creactive protein measurements in patients with non-arteritic anterior ischemic optic neuropathy: a clue to the presence of a microinflammatory response. Acta Ophthalmol. 2008;18. (Epub ahead of print).
16. Su WW, Ho WJ, Cheng ST, et al. Systemic high-sensitivity C-reactive protein levels in normal-tension glaucoma and primary open-angle glaucoma. J Glaucoma. 2007;16: 320-323.
17. Roedl JB, Bleich S, Reulbach U, et al. Homocysteine in tear fluid of patients with pseudoexfoliation glaucoma. J Glaucoma. 2007;16:234-239.
18. Puustjärvi T, Blomster H, KontkanenM, et al. Plasma and aqueous humour levels of homocysteine in exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol. 2004;242:749-754.
19. Su SJ, Huang LW, Pai LS, et al. Homocysteine at pathophysiologic concentrations activates human monocyte and induces cytokine expression and inhibits macrophage migration inhibitory factor expression. Nutrition. 2005;21:994-1002.
20. Tso TK, Huang WN, Huang HY, et al. Relationship of plasma interleukin-18 concentrations to traditional and nontraditional cardiovascular risk factors in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2006;45: 1148-1153.
21. Holven KB, Aukrust P, Retterstol K, et al. Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects. Scand J Clin Lab Invest. 2006;66:45-54.
22. Cumurcu T, Ozyurt H, Demir HD, et al. Serum alpha-1- antitrypsin levels in patients with pseudoexfolative syndrome. Curr Eye Res. 2008;33:159-162.
23. Visontai Z, Merisch B, Kollai M, et al. Increase of carotid artery stiffness and decrease in baroreflex sensitivity in exfoliation syndrome and glaucoma. Br J Ophthalmol. 2006;90:563-567.
24. Resch H, Garhofer G, Fuchsjä ger-Mayrl G, et al. Endothelial dysfunction in glaucoma. Acta Ophthalmol. 2009;87:4-12.
25. Su WW, Cheng ST, Ho WJ, et al. Glaucoma is associated with peripheral vascular endothelial dysfunction. Ophthalmology. 2008;115:1173-1178.
26. Atalar PT, Atalar E, Kilic H, et al. Impaired systemic endothelial function in patients with pseudoexfoliation syndrome. Int Heart J. 2006;47:77-84.
27. Yüksel N, Anik Y, Kilič A, et al. Cerebrovascular blood flow velocities in pseudoexfoliation. Graefes Arch Clin Exp Ophthalmol. 2006;244:316-321.
28. Koz C, Turkcu F, Koz OG, et al. Endothelial function and novel vascular risk factors in pseudoexfoliation syndrome. Eur J Clin Invest. 2008;38:344-345.
29. Henry E, Newby DE, Webb DJ, et al. Peripheral endothelial dysfunction in normal pressure glaucoma. Invest Ophthalmol Vis Sci. 1999;40:1710-1714.
30. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102:2165-2168.
31. Buckley C, Hadoke PWF, Henry E, et al. Systemic vascular endothelial cell dysfunction in normal pressure glaucoma. Br J Ophthalmol. 2002;86:227-232.
32. Su WW, Chung ST, Hsu TS, et al. Abnormal flow-mediated vasodilatation in normal tension glaucoma using a non-invasive determination for peripheral endothelial dysfunction. Invest Ophthalmol Vis Sci. 2006;47:3390-3394.
33. Leibovitch I, Kurtz S, Kesler A, et al. C-reactive protein levels in normal tension glaucoma. J Glaucoma. 2005;14:384-386.